Le Lézard
Classified in: Health
Subjects: AVO, CPG

Kaplan Arbitration Panel Releases Decision on Compensation for Ontario Physicians


Ontario Medical Association (CNW Group/Ontario Medical Association)

TORONTO, Feb. 19, 2019 /CNW/ - We welcome the arbitration panel's decision. This Binding Arbitration award brings a long and difficult period that began in 2015 under the Liberal government to an end and opens the door to a new, more positive relationship with the provincial government. 

While this award does not provide our members - all of the 31,500 practicing physicians in Ontario - with everything we wanted, it does provide for compensation increases, an elimination of payment discounts imposed by the previous government, and no hard cap to the Physician Services Budget. In this, the award provides stability and predictability for the future so that physicians can continue to deliver high-quality health care to all Ontarians. Ultimately, it is Ontario patients that will benefit the most.

We look forward to working with the provincial government, under the leadership of Minister Elliott and Premier Ford, to transform Ontario's health care system and end hallway health care. Our priority is the health and well-being of Ontarians. Our doctors care for more than 300,000 patients every day, and they have been and remain committed to delivering quality health care across the province. 

We thank Mr. Kaplan, the other members of the arbitration panel, and Minister Elliott and Ministry staff for their hard work through this lengthy process.

About the OMA

The Ontario Medical Association is a membership organization that represents the political, clinical and economic interests of doctors in Ontario. Our 41,000 members are practicing and retired doctors, residents and medical students. 

SOURCE Ontario Medical Association


These press releases may also interest you

at 07:05
At the ESCMID Global 2024 conference, Bruker is enhancing its innovative diagnostic solutions in microbial identification, antimicrobial susceptibility testing (AST), early sepsis diagnostics, and other infectious disease assays. Simplifying...

at 07:00
Bristol Myers Squibb today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended approval of Opdivo® (nivolumab) in combination with cisplatin and gemcitabine for the...

at 07:00
R&D Leader and software architect with more than three decades of experience designing, developing,...

at 07:00
Gordian Biotechnology, an in vivo drug discovery and development...

at 07:00
GeBBS Healthcare Solutions, Inc.(ChrysCapital portfolio company) a leading provider of technology enabled Revenue Cycle Management (RCM) & Risk Adjustment Solutions for Healthcare Providers and Payers, announced the acquisition of CCD Health, a...

at 07:00
Many American children...



News published on and distributed by: